The effect of Quince syrup in pediatric gastroesophageal reflux aged 12 to 48 months
- Conditions
- Gastro-oesophageal reflux.Gastro-esophageal reflux disease
- Registration Number
- IRCT20170501033750N2
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Patients in the age group of 12 to 48 months.
People with at least 2 times a week with common symptoms of reflux disease (heartburn, regurgitation, vomiting, epigastric pain and appropriate weight loss for at least a month
Those who are newly diagnosed or who have been suffering from reflux, have not taken any medications for at least one month and will want to start their treatment again
Patients with severe reflux disease (severe onset: symptoms of severe esophagitis, vomiting, life-threatening symptoms such as apnea, pneumonia, esophageal stricture and systemic diseases) due to the need for treatments Another intervention, including surgery or other medications, is withdrawn from the project because of ethical considerations (non-deprivation of the patient and non-risk for the volunteers)
Children with a disease (neurological, cardiac, pulmonary, liver and kidney) or mental retardation
People who have used other herbal remedies during this period
People who need to use chemical drugs during the plan due to the specific disease
People with a history of allergy to herbal medicines
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method